Skip to main content
Clinical Trials/NCT05715593
NCT05715593
Completed
Not Applicable

The Effectiveness of a Health Education Intervention to Reduce Anxiety in Quarantined COVID-19 Patients: A Randomized Controlled Trial

University of Monastir1 site in 1 country402 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Health Education, COVID-19, Quarantine, Anxiety, Pandemic
Sponsor
University of Monastir
Enrollment
402
Locations
1
Primary Endpoint
The rate of anxiety reduction
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period.

Detailed Description

This is a randomized controlled trial conducted between February 2021 and June 2021. Patients tested positive for Covid-19 with mild to moderate forms were randomized to Education (n=267) or control (n=269). The education group received a phone health education session on day 1 (D1) following the diagnosis. The three components of the health education intervention were an explanation of the coronavirus disease, what to do in the event of complications, and the recommended preventive measures. The two groups received a telephone evaluation of their Hospital Anxiety and Depression scores on (D1) and day seven D7 following the positive diagnosis. The primary outcome was the rate of anxiety reduction in each group at D7 based on a HAD-A score ≥ 8. Secondary outcomes were the rate of anxiety reduction at D7 based on a HAD-A score ≥ 11, the percentage of people complying with isolation and the scores of adherence to preventive measures during the isolation in each group.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
July 7, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Imen Zemni

Medical doctor

University of Monastir

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with Covid-19 after positive PCR or positive antigen rapid test, over 18 years of age, who did not require hospitalization

Exclusion Criteria

  • Patients not reachable at the first day phone call of the diagnosis and patients unable to answer the telephone questionnaire due to their cognitive state.

Outcomes

Primary Outcomes

The rate of anxiety reduction

Time Frame: One week (7 days) after the COVID 19 diagnosis

The rate of anxiety reduction in each group at Day 7 based on a HAD-A score ≥ 8

Study Sites (1)

Loading locations...

Similar Trials